Pay in 4 interest-free payments of $5.31 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
PCAC review (July 2026) The FDA stated it intends to consult the Pharmacy Compounding Advisory Committee on July 23, 2026 regarding inclusion of BPC-157 acetate and BPC-157 (free base) on the 503A bulks list
Using a combined treatment plan, doctors can give patients more effective care
TB-500 contributes unique cytoskeletal regulatory mechanisms that enable the enhanced cellular responses to GHK-Cu and BPC-157 signaling
As of 2026, retatrutide has not received marketing authorisation from the MHRA or EMA and is only accessible within authorised clinical trials
US$ 27.71
US$ 25.22
US$ 28.90
US$ 28.10
US$ 20.39
US$ 28.64
US$ 25.41
US$ 20.61
